• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Amicus Opens Philly CoE contractpharma
    March 06, 2020
    Amicus Therapeutics has opened the company’s Global Research and Gene Therapy Center of Excellence in uCity Square in Philadelphia, PA, to advance its portfolio of rare disease gene therapy programs.
  • Amicus Therapeutics expands gene therapy alliance with Penn pharmaceutical-technology
    May 31, 2019
    Amicus Therapeutics has expanded its research and development (R&D) alliance with the Perelman School of Medicine at the University of Pennsylvania (Penn).
  • Amicus’ Galafold receives TGA approval for Fabry disease treatment in Australia pharmaceutical-technology
    August 17, 2017
    Amicus Therapeutics has received the Australian Therapeutic Goods Administration (TGA) approval for Galafold (Migalastat) to treat patients with Fabry disease (alpha-galactosidase A deficiency) in the country.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service